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Essential tremor (ET) is very common, with a
prevalence of 4% in the adult population over
39 years of age and 8.7% in adults over
79 years of age (Dogu et al. 2003). Genetic
factors play a sizable role in disease etiology,
and susceptibility loci have been identiﬁed on
chromosomes 3q13, 2p22, and 6p (Deng et al.
2005; Higgins et al. 1998; Shatunov et al.
2006). Although pair-wise concordance in
monozygotic twins is high (60–93%) (Lorenz
et al. 2004; Tanner et al. 2001), it is not
100%, suggesting an etiologic role for non-
genetic factors in some ET cases (Louis 2001).
Several case–control studies have examined
putative environmental factors, including pes-
ticides (Louis et al. 2006a; Salemi et al. 1998),
manganese and organic solvents (Louis et al.
2004), β-carboline alkaloids (Louis et al.
2005c), and lead (Louis et al. 2003, 2005a).In
a recent case–control study in New York, New
York, blood lead concentrations were elevated
in ET cases compared with matched controls
(Louis et al. 2003, 2005a). Lead is a ubiqui-
tous toxicant (Louis et al. 2003, Schroeder and
Tipton 1968). Laboratory animals and
humans exposed to high levels of lead develop
prominent action tremor (Booze et al. 1983;
Coulehan et al. 1983; Goldings and Stewart
1982; Seshia et al. 1978; Valpey et al. 1978;
Young et al. 1977), with destruction of cere-
bellar Purkinje cells being a major feature of
the pathology of lead toxicity (Valpey et al.
1978). This is of particular interest, given
recent literature demonstrating mild degenera-
tive cerebellar pathology in ET cases (Louis
et al. 2006b, 2006c). It is conceivable that
chronic exposure to lead could produce cere-
bellar damage that then predisposes individu-
als to develop ET. In this case–control study,
ET cases were sampled in the Mersin
Province, Turkey, to determine whether the
elevation in blood lead concentrations
observed in New York was similar to that pre-
sent in ET cases sampled from a completely
different geographic region. An interesting
feature of the study design is that ET cases
were compared both to spouse controls (who
shared the same home environment) and to
nonspouse controls (who did not share the
same home environment).
Methods
Selection of participants. In the Mersin
University Hospital Movement Disorder Unit
database, 250 ET cases are registered. Each
case had a unique registration code and
received a diagnosis of ET from their treating
neurologist in that unit based on the presence
of moderate amplitude action tremor of the
arms or head tremor in the absence of other
etiologies, such as Parkinson disease. Sample
size calculations necessitated 105 cases and
105 controls. Cases who had a ﬁnal registra-
tion code digit of 0, 3, 6, or 9 were first
selected for enrollment, resulting in 80 poten-
tial enrollees. Then, cases with a final digit
code of 2, 5, or 7 were selected, resulting in
additional potential enrollees (total n = 105).
Once selected, cases were asked to enroll in a
study of “environmental risk factors for
tremor.” Ninety-two (87.6%) cases agreed to
be enrolled and 13 declined enrollment;
13 replacement cases were selected based on
their digit code, bringing the number of cases
up to 105. Most controls were the spouses of
the cases [n = 69 (65.7%) of 105]. When
spouses were not available (18 spouses had
died and 18 either refused or could not come
to the university), a relative was then selected
who lived in the same district in Mersin and
was closest in age to the case (nonspouse con-
trols; n = 36). Eleven (10.5%) controls
declined enrollment, so additional controls
had to be selected to obtain the targeted num-
ber of 105 controls. Before enrollment, the
Mersin University Institutional Review Board
approved all study procedures, and written
informed consent was obtained at the time of
enrollment. Enrollment began on 12 February
2003 and ended on 15 December 2004.
Demographic and medical history. Once
enrolled, all participants were evaluated in per-
son by a neurologist (O.U.), who administered
clinical questionnaires and performed a video-
taped examination. Data were collected on age,
sex, education, cigarette smoking (yes vs. no),
cigarette pack-years, ethanol use (yes vs. no),
and medication use. ET cases were asked
whether they had a first-degree relative with
ET. Current occupation was coded into 10 cat-
egories (Table 1). Data on past occupation or
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BACKGROUND: Essential tremor (ET) is one of the most common neurologic disorders. Aside from
underlying susceptibility genes, recent studies have also begun to focus on environmental toxic fac-
tors. Yet there remains a paucity of information on such factors, making studies of environmental
factors important. A recent study in New York City found blood lead concentrations to be elevated
in ET cases compared with matched controls. Chronic exposure to lead produces cerebellar dam-
age, and this could predispose individuals to develop ET.
OBJECTIVE: The aim of this study was to determine whether the elevation in blood lead concentra-
tions observed in a single study in New York was similarly present in ET cases sampled from a
completely different geographic region.
METHODS: Blood lead concentrations were measured in 105 ET cases and 105 controls at Mersin
University, Mersin, Turkey.
RESULTS: The median blood lead concentration was 2.7 µg/dL in ET cases compared with
1.5 µg/dL in controls (p < 0.001). In an unadjusted logistic regression model, blood lead concentra-
tion was associated with diagnosis: odds ratio (OR) = 4.01; 95% confidence interval (CI),
2.53–6.37; p < 0.001 (i.e., each 1-µg/dL increase in blood lead concentration was associated with a
4-fold increased odds of ET). This association was more robust when cases were compared with a
subsample of controls who did not share the same home environment (OR = 8.13; 95% CI,
3.05–21.65; p < 0.001). In adjusted models, results were similar.
CONCLUSIONS: These data replicate those of a previous study in New York and demonstrate an asso-
ciation between the environmental toxicant lead and a common neurologic disorder.
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1 August 2007]occupation at the time of diagnosis were
not collected.
Videotaped examination. For all partici-
pants, the tester videotaped a tremor examina-
tion that included one test to elicit postural
tremor (sustained arm extension) and ﬁve tests
to elicit kinetic tremor (Louis et al. 2003,
2005a). Each of the six tests was performed
with each arm (12 tests total) (Louis et al.
2003, 2005a). Each videotape was reviewed by
the senior investigator (O.D.), who rated
tremor during each of the 12 tests using a 0–3
scale [total tremor score = 0–36 (maximum)]
(Louis et al. 2003, 2005a). These ratings were
performed blinded to data on blood lead con-
centrations. O.D. was formally trained to rate
tremor using a published teaching videotape
(Louis et al. 2001) that included an educa-
tional section and a self-assessment section
(ratings of 20 items); his 20 ratings demon-
strated substantive agreement with published
ratings (weighted kappa statistic = 0.81), indi-
cating that his ratings were in agreement with
standardized, published ratings of tremor.
O.D. also confirmed the diagnosis of ET
using published diagnostic criteria [moderate
or greater amplitude tremor (tremor rating
≥ 2) during three or more activities or a head
tremor in the absence of competing diagnoses
such as Parkinson disease] (Louis et al. 1997).
Determination of blood lead concentra-
tions. On the same day as the clinical question-
naires and videotaped examination, 10-mL
blood samples were collected in lead-free stop-
pered pyrex tubes containing 100 units of
heparin. Six milliliters of this heparinized
blood was hemolysed with Triton X-100
(octylphenoxypolyethoxyethanol; Sigma
092K0172; Sigma Chemical Co., St. Louis,
MO, USA) and analyzed according to the
method described by Zinterhofer et al. (1971)
using a UNICAM 929 atomic absorption
spectrophotometer (UNICAM, Portsmouth,
NH, USA) in a trace metal–free environment
(Laboratory of Biochemistry, Atomic
Absorption Unit, Mersin Hospital). These
analyses were performed blinded to clinical
information. The detection limit for blood lead
using these instruments was 0.1 µg/dL.
Intersubject and intrasubject coefficients of
variation (CVs) for the lead assay were 0.67%
and 0.47%, respectively.
Statistical analyses. Statistical analyses were
performed using SPSS, version 13.0 (SPSS
Inc., Chicago, IL, USA). Blood lead concentra-
tions were not normally distributed. Each
analysis was ﬁrst performed using log10 blood
lead and then repeated using blood lead. The
results were similar. Results were presented
using blood lead because nontransformed data
can be expressed in units of micrograms per
deciliter, which is a more easily understand-
able unit of measure. When examining group
differences in blood lead concentration, we
compared medians using a nonparametric
approach (Mann-Whitney test). To assess
associations between blood lead concentration
and other continuous variables (e.g., total
tremor score) we used Spearman’s correlation
coefficients. To evaluate differences between
categorical variables, chi-square tests were
used. To assess group differences in normally
distributed continuous variables, we used the
Student’s t-test. 
Logistic regression analyses were per-
formed. A priori, the main analysis was to test
the association between blood lead concentra-
tion (independent variable) and diagnosis (ET
case vs. control, dependent variable). We
began with an unadjusted model and then
individually considered variables that were
suspected to confound the lead–diagnosis
association or were known to be associated
with blood lead concentration (Louis et al.
2003, 2005a). These were age in years, sex,
years of education, current cigarette smoker
(yes vs. no), pack-years of smoking, and
ethanol use (yes vs. no). We did not need to
consider race because this was homogeneous
in our sample. Because dietary data were not
available, we did not consider reported daily
consumptions of vitamin C, calcium, and
iron. The confounding variables were entered
into the final adjusted multivariate logistic
regression model (enter approach) if they
were associated with the dependent variable
in univariate analyses or if prior evidence sup-
ported an association with either blood lead
concentration or ET (Louis et al. 2003,
2005a).
Results
Cases and controls. The study included
105 ET cases and 105 controls (including
69 spouses and 36 nonspouses). ET cases had a
mean ± SD total tremor score of 18.0 ± 6.2
and mean disease duration of 9.6 ± 10.4
(range, 1–49) years; 68 (64.8%) reported hav-
ing a family history of ET (i.e., an affected
first-degree relative), 31 (29.5%) had head
tremor on examination, and 56 (53.3%) were
taking medication to treat tremor. Controls
had a mean total tremor score of 1.0 ± 2.9
and none had ET; 8 (7.6%) had a family his-
tory of ET. ET cases and control subjects
were similar in terms of age and other demo-
graphic variables (Table 1). Data on current
occupation were available on 104 ET cases
and 105 controls (Table 1); a larger propor-
tion of ET cases was retired compared with
controls.
Spouse controls and nonspouse controls
had marginally different blood lead concen-
trations, with spouse controls having margin-
ally higher blood lead concentrations than
controls who did not share the same home
environment with the cases (mean ± SD, 1.64
± 0.90 µg/dL vs. 1.44 ± 0.35 µg/dL; medians,
1.5 µg/dL vs. 1.3 µg/dL; Mann-Whitney z =
1.52; p = 0.13). Among controls, blood lead
concentration was not signiﬁcantly associated
with age (r = –0.04; p = 0.69), sex (both
medians = 1.5 µg/dL; Mann-Whitney z =
0.60; p = 0.55), education (r = 0.14; p =
0.16), cigarette smoking (both medians = 1.5
µg/dL; Mann-Whitney z = 0.99; p = 0.32),
cigarette pack-years (r = 0.11; p = 0.28), or
ethanol use (both medians = 1.5 µg/dL;
Mann-Whitney z = 0.62; p = 0.54). The
median blood lead concentration among
retired controls (1.3 µg/dL) was marginally
lower than that of nonretirees (1.5 µg/dL;
Mann-Whitney z = 1.6; p = 0.10).
Among cases, blood lead concentration was
not signiﬁcantly associated with age (r = 0.12;
p = 0.22), sex (median in males = 3.1 µg/dL; in
females = 2.5 µg/dL; Mann-Whitney z = 1.33;
p = 0.19), cigarette smoking (median in
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Table 1. Demographic characteristics of ET cases and controls.
Controls
ET cases All Spouse Nonspouse
Characteristic (n = 105) (n = 105) (n = 69) (n = 36)
Age (years) 52.9 ± 18.6 50.7 ± 13.7 50.9 ± 12.5 50.3 ± 15.9
Female sex  42 (40.0) 42 (40.0) 36 (52.2) 6 (16.7)*
Education (years) 8.7 ± 4.1 8.5 ± 3.9 8.4 ± 3.9 8.7 ± 4.0
Current cigarette smoker 28 (26.7) 35 (33.3) 19 (27.5) 16 (44.4)*
Cigarette pack-years 3.7 ± 7.5 4.8 ± 7.9 3.8 ± 7.7 6.6 ± 8.2
Ethanol user 33 (31.4) 24 (22.9) 11 (15.9)* 13 (36.1)
Current occupation
Housewife 28 (26.9) 33 (31.4) 25 (36.2) 8 (22.2)
Ofﬁcer 8 (7.7) 12 (11.4) 9 (13.0) 3 (8.3)
Farmer 0 (0.0) 4 (3.8) 0 (0.0) 4 (11.1)
Industrial worker 2 (1.9) 1 (1.0) 0 (0.0) 1 (2.8)
Student 6 (5.8) 2 (1.9) 2 (2.9) 0 (0.0)
Retailer 6 (5.8) 14 (13.3) 6 (8.7) 8 (22.2)
Unemployed 2 (1.9) 3 (2.9) 2 (2.9) 1 (2.8)
Retired 46 (44.2) 30 (28.6)* 21 (30.4) 9 (25.0)*
Teacher 4 (3.8) 4 (3.8) 3 (4.3) 1 (2.8)
Health care 2 (1.9) 2 (1.9) 1 (1.4) 1 (2.8)
Values shown are mean ± SD or no. (%). 
*p < 0.05 compared with ET cases.smokers = 3.3 µg/dL; in nonsmokers =
2.7 µg/dL; Mann-Whitney z = 0.47; p =
0.64), cigarette pack-years (r = 0.05; p = 0.59),
or ethanol use (both medians = 2.7 µg/dL;
Mann-Whitney z = 1.01; p = 0.31). Among
cases, blood lead concentration was margin-
ally associated with education (r = 0.19; p =
0.06). The median blood lead concentration
was the same in retired and nonretired cases
(both medians = 2.7 µg/dL; Mann-Whitney z
= 0.02; p = 0.98).
Blood lead concentrations. The median
blood lead concentration in ET cases was
2.7 µg/dL compared with 1.5 µg/dL in con-
trols (Mann-Whitney z = 8.12; p < 0.001).
The mean (± SD) blood lead concentrations
were 3.2 ± 1.9 µg/dL (range = 0.8–9.4 µg/dL)
for cases and 1.6 ± 0.8 µg/dL (range = 0.7–8.0
µg/dL) for controls. The median blood lead
concentration in ET cases (2.7 µg/dL) was
higher than that of spouse controls (1.5 µg/dL;
Mann-Whitney z = 6.91; p < 0.001) and non-
spouse controls (1.3 µg/dL; Mann-Whitney
z = 6.25; p < 0.001) (Figure 1).
In an unadjusted logistic regression model,
blood lead concentration was associated with
diagnosis (control vs. ET case): odds ratio
(OR) = 4.01; 95% confidence interval (CI),
2.53–6.37; p < 0.001 (i.e., each 1-µg/dL
increase in blood lead concentration was asso-
ciated with a 4-fold increased odds of ET)
(Table 2). In a series of six logistic regression
models, we adjusted for a variety of covariates
(in each model we included blood lead concen-
tration and one covariate); in these analyses,
the association between blood lead concentra-
tion and ET remained robust (Table 2). In a
model in which we simultaneously adjusted for
age, sex, education, cigarette smoking (yes vs.
no), cigarette pack-years, and ethanol use (yes
vs. no.), blood lead concentration was associ-
ated with diagnosis (OR = 4.19; 95% CI,
2.59–6.78; p < 0.001). Adding current occupa-
tion (retired vs. nonretired) to the model did
not change the results. This association was
more robust when ET cases were compared
with nonspouse controls (unadjusted OR =
8.13; 95% CI, 3.05–21.65; p < 0.001; and
adjusted OR = 9.87; 95% CI, 2.49–39.22;
p = 0.001) than with spouse controls (unad-
justed OR = 3.28; 95% CI, 2.06–5.23;
p < 0.001; and adjusted OR = 3.39; 95% CI,
1.96–5.87; p < 0.001).
We found a correlation between tremor
severity (total tremor score) and blood lead
concentration (r = 0.48; p < 0.001) in the
entire sample. This correlation was likely a
reﬂection of the difference between cases and
controls because it was not present in analyses
restricted to ET cases (r = –0.12; p = 0.23).
The correlation between blood lead concentra-
tion and tremor duration in ET cases was not
signiﬁcant (r = 0.17; p = 0.09), especially after
adjusting for age (r = 0.05; p = 0.62). ET cases
were stratiﬁed based on whether each case cur-
rently took medication for ET, had a family
history of ET, or had head tremor, but there
were no differences with respect to median
blood lead concentrations.
Discussion
Given the paucity of information on risk fac-
tors for ET, studies of environmental factors
are important. In a previous study, blood lead
concentrations were elevated in ET cases
compared with matched controls. Now, in
this case–control study in Mersin, Turkey, we
found that blood lead concentrations were
approximately doubled in ET cases compared
with their counterparts without ET. This
association between higher blood lead con-
centration and the diagnosed ET persisted
after adjusting for confounding variables.
This association was particularly robust when
ET cases were compared with controls who
did not share their same home environment
(i.e., nonspouse controls); in these analyses,
each 1-µg/dL increase in blood lead con-
centration was associated with an 8-fold
increased odds of having ET.
The present results are similar to those of
the New York study (Louis et al. 2003, 2005a)
in the sense that ET was associated with a
modest yet significant increase in blood lead
concentration. The higher ORs in the present
study are probably due to the fact that blood
lead concentrations were slightly lower in the
Mersin controls than the New York controls
(Louis et al. 2003, 2005a).
Blood lead concentrations in ET cases
were higher than those observed in both types
of controls. These data suggest that the
increased blood lead concentration in these
ET cases is robust. It is not clear whether the
difference between cases and controls is due to
increased environmental exposure or genetic
differences in lead metabolism. Previous work
in New York suggests that lead metabolism
may be altered in ET cases compared with
control subjects; in that study (Louis et al.
2005a), the odds of ET were greatly elevated
(OR = 80.29; 95% CI, 3.08–2096.36; p =
0.008) in individuals with both a δ-amino-
levulinic acid dehydratase-2 allele and an
elevated blood lead concentration. 
Although the blood lead concentration
differed between ET cases and controls, as in
the previous study in New York (Louis et al.
2003, 2005a), the concentrations in these
study participants were relatively low.
However, evidence suggests that low levels
may be associated with adverse health effects.
In a report of 141 men taking part in a nor-
mative aging study, with mean blood lead
concentrations of 5.5 µg/dL (Payton et al.
1998), higher concentrations of blood and
bone lead were associated with poorer perfor-
mance on cognitive tests. In a study of older
women (Muldoon et al. 1996), blood lead lev-
els as low as 8 µg/dL were signiﬁcantly associ-
ated with poorer cognitive function as
measured by certain neuropsychologic tests.
Lead exposure may also be associated with
other neurologic diseases, although the num-
ber of such studies is small. In one study
(Kamel et al. 2005), amyotrophic lateral scle-
rosis was associated with self-reported occupa-
tional lead exposure and blood and bone lead
levels. In another study (Coon et al. 2006),
risk of Parkinson disease was elevated among
individuals in the highest quartile for lifetime
lead exposure.
Dogu et al.
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Table 2. Logistic regression models.
p-Value for each 
Model Variables in model OR (95% CI) variable in the model
1 Blood lead concentration 4.01 (2.53–6.37) < 0.001
2 Blood lead concentration 4.00 (2.51–6.37) < 0.001
Age in years 1.001 (0.98–1.02) 0.94
3 Blood lead concentration 4.02 (2.53–6.37) < 0.001
Female sex 1.14 (0.59–2.21) 0.70
4 Blood lead concentration 4.12 (2.58–6.60) < 0.001
Education (years) 0.96 (0.88–1.04) 0.31
5 Blood lead concentration 4.10 (2.57–6.54) < 0.001
Current cigarette smoker 0.60 (0.29–1.26) 0.18
6 Blood lead concentration 4.09 (2.57–6.52) < 0.001
Cigarette pack-years 0.97 (0.93–1.02) 0.18
7 Blood lead concentration 3.97 (2.50–6.30) < 0.001
Ethanol user 1.23 (0.59–2.59) 0.58
Figure 1. Box plot of blood lead concentrations in
ET cases, spouse controls, and nonspouse con-
trols. Horizontal lines indicate the median; boxes
represent the interquartile range; whiskers indi-
cate quartiles; and circles indicate outliers.
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)Humans may be exposed both to inor-
ganic and organic forms of lead from a variety
of occupational and nonoccupational sources
(Coulehan et al. 1983; Winegar et al. 1997).
In humans and laboratory animals, lead expo-
sure may lead to acute and chronic progres-
sive disorders in which action tremor is a
prominent feature (Booze et al. 1983;
Coulehan et al. 1983; Goldings and Stewart
1982; Seshia et al. 1978; Valpey et al. 1978;
Young et al. 1977). Lead toxicity causes cere-
bellar pathology. Rat pups fed a diet contain-
ing 4% lead acetate demonstrated changes in
the topology of Purkinje cell dendritic trees
due to a change in Purkinje cell metabolism
(McConnell and Berry 1979). Perinatal expo-
sure to inorganic lead results in degenerative
changes in Purkinje cells in the rabbit cerebel-
lum (Walsh and Tilson 1984). An autopsy
study of humans with chronic organic lead
exposure revealed severe destruction of cere-
bellar Purkinje cells (Valpey et al. 1978).
Multiple lines of evidence suggest that the
cerebellum is abnormal in ET, including
clinical, imaging, electrophysiologic, and
recent pathologic studies (Louis et al. 2006b,
2006c; Stolze et al. 2000; Wills et al. 1994).
Given the cerebellar toxicity of lead (Valpey
et al. 1978; McConnell and Berry 1979;
Walsh and Tilson 1984) and the emerging
links between ET and cerebellar degeneration
(Louis et al. 2006b, 2006c; Stolze et al. 2000;
Wills et al. 1994), it seems plausible that the
association between the two could be robust.
The present analyses were cross-sectional.
The data do not directly address the issue of
whether higher blood lead concentrations
preceded or followed the diagnosis of ET.
Prospective studies are needed to assess
causality by assessing whether a higher pre-
disease blood lead concentration is associated
with an increased risk of developing incident
ET. One possibility is that higher blood lead
concentrations result in ET, with a possible
mechanism being lead-induced cerebellar
damage. Another possibility is the converse,
namely, that having ET results in higher
blood lead concentrations, although the
potential mechanisms for such a relationship
are not readily apparent. A ﬁnal possibility is
that some common underlying factor (e.g., a
genetic predisposition) leads both to ET and
to elevated blood lead concentrations.
Our study had additional limitations.
First, our occupational assessment was limited
to current occupation rather than lifetime
occupation. However, in the previous report
(Louis et al. 2003), which used lifetime occu-
pational histories to estimate the probability
of lifetime occupational exposures to lead, no
association was found between ET and occu-
pations with lead exposure. Also, in Mersin,
the place of residence and occupation are
relatively stable compared with areas where
residents are more highly educated, mobile,
and wealthier; therefore current occupation in
the present study likely reﬂects lifetime occu-
pation. Second, dietary data were not avail-
able, so we were not able to adjust for
reported daily consumptions of vitamin C,
calcium, and iron, which have been reported
to be associated with higher blood lead levels
(Louis et al. 2003, 2005a). However, in our
previous study (Louis et al. 2003) in which
we adjusted for these dietary factors, the case–
control differences in blood lead concentra-
tion remained robust. Also, in a published
comparison of several hundred ET cases and
control subjects (Louis et al. 2005b), daily
dietary consumption of vitamin C, calcium,
and iron did not differ. However, the effect of
these unmeasured confounders on our ORs is
not known. Third, we assessed blood lead
concentrations rather than bone lead concen-
trations. Bone lead concentrations are a better
measure of cumulative exposure to lead,
although there is a correlation between the
two in “steady-state” exposure (Cheng et al.
1998). Our use of blood lead as a measure of
lead exposure might not have optimized our
ability to detect an association between lead
exposure and ET. Fourth, our sample was
from a tertiary referral hospital that contains
the only movement disorder unit in the
region. Hence, the sample was not population
based, so we cannot necessarily generalize our
results to ET cases ascertained directly from
the population of Mersin. Although it is pos-
sible that selection bias accounted for our
observations, this is unlikely; the selection of
ET cases was not predicated on their blood
lead concentrations, which were assessed only
after they had visited the Movement Disorder
Unit. Finally, although the use of spouses as
controls can lead to limitations (in this setting
because they shared the same home environ-
ment), this would have biased our results
toward rather than away from the null
hypothesis. Furthermore, we also enrolled a
sample of nonspouse controls and demon-
strated a difference between cases and controls
as well. In spite of these limitations, this is
one of only two studies to explore differences
in blood lead concentrations between ET
cases and controls.
In summary, data in the present study
replicate those of a previous study conducted
in New York (Louis et al. 2003, 2005a) and
demonstrate an association between the envi-
ronmental toxicant lead and a common neu-
rologic disease, ET. In doing so, they provide
additional support for the notion that envi-
ronmental factors could be involved in disease
etiology. Prospective studies are needed to
assess causality by assessing whether a higher
predisease blood lead concentration is associ-
ated with an increased risk of developing
incident ET.
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